← Eichor
Study identifier: NCT06289270 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.

Condition: Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer Tissues  ·  Sponsor: Theodor Bilharz Research Institute

PhaseN/A
Planned participants38
Who can joinMale, 18 Years to no upper limit
Healthy volunteersYes

About this study

Microbes inhabiting the urinary tract that are playing an important role in maintenance of health and the development of diseases and bladder cancer. There is correlation between initiation of bladder cancer and microbes. Urine and bladder tissues from healthy individuals and patients with bladder cancer were analyzed using 16S rRNA sequencing, results show abundant phylum. Next-generation sequencing technologies will be applied with whole genomic and 16S ribosomal RNA gene sequencing for microbiota profiling in urine and bladder tissue of male healthy individuals and patients with bladder cancer. Results will lead to prevention, diagnosis, and new treatment strategies for bladder cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Mohamed M Wishahi, MD  ·  +201222247437  ·  wishahi@gmx.net

Mohamed Wishahi, MD  ·  +491744120184  ·  wishahi@gmx.net

Always discuss trial participation with your own doctor first.

Locations (2)

Theodor Bilharz Research InstituteCairo, Giza Governorate, EgyptNot Yet Recruiting
Theodor Bilharz Research InstituteCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06289270